Testosterone Nasal Gels Market
Testosterone Nasal Gels Market Share Analysis By Indication (Primary hypogonadism, Hypogonadotropic hypogonadism), By Dosage (5mg, 10mg), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies) & By Region - Global Insights 2021 to 2031
Analysis of Testosterone Nasal Gels Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Testosterone Nasal Gels Market Forecast and CAGR
According to the latest research by Fact MR, the testosterone nasal gels market will experience substantial growth with a CAGR of 3% during the forecast period 2021-2031.
The hormone testosterone is in charge of the development of male sex organs, male fertility, spermatogenesis and secondary characteristics. Testosterone nasal gels are used for the treatment of conditions like hypogonadism. In this condition, the body does not make sufficient natural testosterone. The market is mainly driven by the prevalence of hypogonadism, new product launches and collaborations among the players.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Testosterone Nasal Gels?
For the treatment of hypogonadism and other conditions like Klinefelter syndrome, testosterone replacement therapy is given. During this therapy, supplements containing testosterone is administrated.
The major factors driving the demand for testosterone nasal gels is the rise in prevalence of hypogonadism, new product launches and collaborations among the players. According to a report, Klinefelter syndrome is one of the most common chromosomal disorders in newborns resulting in 1 in every 500 – 1000 newborns.
The prevalence of hypogonadism is common among the older male population ageing above 60 years of age. The increasing ageing population can also act as a driver for the testosterone nasal gels market.
The advantages offered by the testosterone nasal gel over the injectable form is also huge. This includes a less invasive delivery method, self-administered medications, early-onset, etc. these advantages acts as a driver for the market resulting in the surge in demand for testosterone nasal gels during the forecast period.
Impact of COVID on Testosterone Nasal Gels Market
A study conducted by the University of Mersin and the Mersin City Education and Research Hospital in Turkey found that males affected with COVID-19 showed a decrease in testosterone levels. It showed that as the severity of COVID increased, the total testosterone levels decreased leading to hypogonadism. Therefore, this will surge the demand for testosterone replacement therapy hence driving the market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Regional Outlook for Testosterone Nasal Gels
The market is dominated by the North American region. This is due to the presence of the major player in the market. Natesto is the only FDA approved testosterone nasal gel and is manufactured by Acerus Pharmaceuticals Corporation situated in Canada. To make sales globally, the company collaborates with other companies for marketing its product globally.
For instance, Acerus Pharmaceuticals Corporation in collaboration with Hyundai Pharm Co. launched Natesto in South Korea. Apart from this hypogonadism affects approximately 4 to 5 million males in the U.S. These factors are responsible for growth in this region.
Who are the Key Manufacturers and Suppliers of Testosterone Nasal Gels?
Some of the leading manufacturers operating in the testosterone nasal gels include
- Acerus Pharmaceuticals Corporation
- Hyundai Pharm Co.
- Endo Pharmaceuticals Inc.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Testosterone Nasal Gels Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Key Segments
-
By Indication:
- Primary hypogonadism
- Hypogonadotropic hypogonadism
-
By Dosage:
- 5mg
- 10mg
-
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Indication 6.2. Dosage 6.3. Distribution Channel 7. Global Market Analysis and Forecast, By Indication 7.1. Primary hypogonadism 7.2. Hypogonadotropic hypogonadism 8. Global Market Analysis and Forecast, By Dosage 8.1. 5mg 8.2. 10mg 9. Global Market Analysis and Forecast, By Distribution Channel 9.1. Hospital Pharmacies 9.2. Retail Pharmacies 9.3. Mail Order Pharmacies 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. MEA 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. MEA Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Indication, Dosage, and Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Acerus Pharmaceuticals Corporation 20.2. Hyundai Pharm Co. 20.3. Endo Pharmaceuticals Inc.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Indication
Table 3: Global Market US$ Mn Forecast by Dosage
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Indication
Table 7: North America Market US$ Mn Forecast by Dosage
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Indication
Table 11: Latin America Market US$ Mn Forecast by Dosage
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Indication
Table 15: Western Europe Market US$ Mn Forecast by Dosage
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Indication
Table 19: Eastern Europe Market US$ Mn Forecast by Dosage
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Indication
Table 23: East Asia Market US$ Mn Forecast by Dosage
Table 24: East Asia Market US$ Mn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Indication
Table 27: South Asia & Pacific Market US$ Mn Forecast by Dosage
Table 28: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Indication
Table 31: MEA Market US$ Mn Forecast by Dosage
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the growth outlook for the testosterone nasal gels market by 2031?
The testosterone nasal gels market will experience substantial growth with a CAGR of 3% during the forecast period.
Which factors are driving demand for the testosterone nasal gels market?
The factors driving demand for testosterone nasal gels are the rise in the prevalence of hypogonadism and new product launches.
Which region is dominating the testosterone nasal gels market until 2031?
The market is dominated by the North American region. This is due to the presence of the major player in the market.
Testosterone Nasal Gels Market